Brief: Bioinvent: Promising Progress In Phase I/LLA Trial Of Lead Program BI-1206 In Combination With Rituximab

BioInvent International AB

14/04/2020 07:11

April 14 (Reuters) - BioInvent International AB  BINV.ST :
    * BIOINVENT REPORTS PROMISING PROGRESS IN PHASE I/LLA TRIAL
OF
LEAD PROGRAM BI-1206 IN COMBINATION WITH RITUXIMAB
    * EARLY RESULTS FROM PHASE I PART OF TRIAL ARE ON TRACK FOR
H2
2020
    * WE ARE CLOSELY MONITORING SPREAD OF COVID-19 AND FOR NOW,
OUR
ONGOING CLINICAL TRIALS AND PLANNED INITIATIONS REMAIN ON TRACK
    * WE ARE VERY PLEASED TO OBSERVE INITIAL SIGNS OF EFFICACY

Source text for Eikon:  ID:nWkr9WRdw5 
Further company coverage:  BINV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))